Diabet Med 34(9):12281234
They found that GLP-1 users experienced chronic cough approximately 29% more often than patients taking alternatives such as DPP-4 inhibitors, SGLT2 inhibitors, and sulfonylureas
Conclusion: Injectable therapies such as GLP-1, Ozempic, Wegovy, and Trulicity represent valuable additions to the armamentarium for weight management, diabetes treatment, and prediabetes management
While BW reduction likely contributes to improvements in conditions, such as hepatic steatosis or sleep apnea, GLP-1 RAs may also exert direct disease-specific effects, particularly through central mechanisms implicated in neurodegeneration and addiction [39]
GLP-1 has been shown to attenuate meal-induced gastric antral propagated contractions while increasing pyloric tone (159, 160)
cnbc.com 3CNBC Healthy Returns (July 8, 2026)